Articles related to Infectious Diseases

The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.

With a significant rise in meningococcal disease cases in 2023 and continuing into 2024, physicians must be alert for non-traditional symptoms such as septic arthritis and bacteremia to ensure timely and effective patient management.

Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.

This “From the Editor” in the Cleveland Clinic Journal of Medicine offers a nuanced view of corticosteroid therapy, highlighting the balance between their significant therapeutic benefits and the risk of adverse effects in long-term use.

MySTIRisk’s AI-driven analysis offers a nuanced approach to identifying patients at heightened risk for STIs, providing a crucial tool in optimizing healthcare strategies and interventions in sexual health clinics.

In the battle against recurrent herpes simplex virus infections, chronic suppressive therapy emerges as a pivotal strategy, diminishing both the physical burden of outbreaks and the psychological weight of potential transmission.